Publications
January 1, 2024 - December 31, 2024
An C, Jeong J, Chiu C, Kennedy AG, Sternberg K. Risk Stratification and Diagnostic Evaluation of Patients Found to Have Microscopic Hematuria by Their Primary Care Providers. Accepted to Journal of General and Family Medicine (October 2024).
Bergeron J, Marchese C, Jensen C, et al. Nephrology providers' perspective and use of mortality prognostic tools in dialysis patients. BMC Nephrol. Nov 26 2024;25(1):425. doi:10.1186/s12882-024-03861-y
Bonnell LN, Clifton J, Natkin LW, Hitt JR, Littenberg B. The association of self-perceived changes due to covid-19 with mental and physical health among adult primary care patients with multiple chronic conditions: A us-based longitudinal study. J Multimorb Comorb. Jan-Dec 2024;14:26335565231222148. doi:10.1177/26335565231222148
Brasch CW and Repp AB. Subacute Invasive Pulmonary Aspergillosis Presenting with Pneumothorax. Annals of Internal Medicine Clinical Cases, 2024. In press.
Crooker KG, Stedman ER, Hitt JR, Tompkins BJ, Repp AB. Causes and outcomes of non-chemotherapy induced neutropenic fever in hospitalized adults: An observational study. Medicine (Baltimore). May 3 2024;103(18):e38060. doi:10.1097/md.0000000000038060
Gabbay J, Kennedy AG, Hitt J, Gilbert M, Barrett K. The Cardiometabolic Clinic: Bridging Gaps in Care. J Endocrinol Metab. 2024;14(5):221-225. doi: https://doi.org/10.14740/jem1018
Hirve AA, Repp AB, Burgess LK. Things we do for no reason™: Obtaining an electrocardiogram for managing mild hyperkalemia in hospitalized adults. J Hosp Med. Sep 2024;19(9):841-844. doi:10.1002/jhm.13288
Jankowska M, Dessureault K, Kennedy AG, MacDougall J, Sowers M, Merchand M. Impact of non-medical switches from reference infliximab to biosimilars on disease control within a rheumatology practice. Accepted to Journal of Pharmacy Technology (December 2024).
Lam MI, Gleason K, Repp AB, et al. The spatial and temporal effect of electrochromic windows on indoor and human microbiome in an inpatient hospital. Antimicrob Steward Healthc Epidemiol. 2024;4(1):e188. doi:10.1017/ash.2024.344
McEntee RK, Hitt J, Sieja A. Taking a team approach: Keep up with the ehr with a training and optimization program. Appl Clin Inform. Oct 9 2024;doi:10.1055/a-2437-0185
Repp AB, Sparks AD, Wilkinson K, et al. Factors associated with venous thromboembolism pharmacoprophylaxis initiation in hospitalized medical patients: The medical inpatients thrombosis and hemostasis study. Journal of thrombosis and haemostasis : JTH. Sep 12 2024;doi:10.1016/j.jtha.2024.08.016
Riser E, Kennedy AG, Holterman LA, Brooklyn J, Maruti S, Sobel HG. Preparing medical students to care for patients with opioid use disorder: Buprenorphine waiver training in undergraduate medical education. Academic psychiatry : the journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry. Jun 2024;48(3):263-267. doi:10.1007/s40596-024-01968-w
van Eeghen C, Soucie J, Clifton J, et al. Implementation outcomes from a randomized, controlled trial of a strategy to improve integration of behavioral health and primary care services. BMC Health Serv Res. Nov 8 2024;24(1):1361. doi:10.1186/s12913-024-11801-7
Wilkinson KS, Sparks AD, Gergi M, et al. Validation of the international medical prevention registry on venous thromboembolism (improve) risk scores for venous thromboembolism and bleeding in an independent population. Res Pract Thromb Haemost. May 2024;8(4):102441. doi:10.1016/j.rpth.2024.102441
Wood M, Kennedy AG, Khan S, et al. Impact of glp-1 receptor agonist use in patients with steatotic liver disease and type 2 diabetes: A retrospective cohort study. J Pharm Pract. Dec 2024;37(6):1297-1302. doi:10.1177/08971900241253661
Zakai NA, Wilkinson K, Sparks AD, et al. Development and validation of a risk model for hospital-acquired venous thrombosis: The medical inpatients thrombosis and hemostasis study. Journal of thrombosis and haemostasis : JTH. Feb 2024;22(2):503-515. doi:10.1016/j.jtha.2023.10.015
Zakai NA, Wilkinson KS, Sparks AD, et al. Authors' response to "venous thromboembolism risk models in hospitalized medical patients: The time for implementation, not never-ending development". Res Pract Thromb Haemost. May 2024;8(4):102483. doi:10.1016/j.rpth.2024.10248